Vision training and atropine for myopia in children
Part of Eyes & vision clinical trials.
This study tests if combining a daily VR vision-training program with low-dose atropine eye drops can slow down or prevent myopia (nearsightedness) from getting worse in children. Participants wear special glasses that help focus light properly and either use atropine alone or atropine plus the VR training.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 and 12 years old
- Nearsightedness (myopia) in both eyes, with a prescription between -1.00 and -6.00 diopters
- Good corrected vision – at least 0.8 (80%) in the right eye with glasses/contacts
- No other eye conditions or treatments for myopia in the past 6 months (like atropine or special lenses)
- Willing to wear special glasses for at least 10 hours a day and, if in the experimental group, do a 18-minute VR training each night plus use atropine drops before bed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This trial tests a special contact lens combined with atropine eye drops to see if they work better together to slow down worsening nearsightedness (myopia) in children. It might be a good option if your child's eyes are getting more nearsighted and they haven't tried other treatments yet.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.